HealthStream, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. This is an annual filing, not a standalone fourth-quarter report. HealthStream provides primarily subscription-based software and services for healthcare workforce learning, development, scheduling, credentialing, and related needs. Since January 1, 2023, it has reported as one segment under its consolidated “One HealthStream” approach, centered on the hStream platform.
Financial performance
| Metric | FY2023 | FY2022 | Change |
|---|---|---|---|
| Revenue | $279.1 million | $266.8 million | +5% |
| Subscription revenue | $267.9 million | $254.0 million | +6% |
| Professional services revenue | $11.1 million | $12.9 million | -14% |
| Gross margin | 65.9% | 65.8% | +0.1 percentage point |
| Operating income | $16.0 million | $12.4 million | +29% |
| Net income | $15.2 million | $12.1 million | +26% |
| Diluted EPS | $0.50 | $0.39 | Up |
| Adjusted EBITDA | $61.3 million | $53.4 million | +15% |
| Cash from operations | $64.0 million | $51.2 million | +25% |
Adjusted EBITDA is a non-GAAP measure. Revenue was approximately 96% subscription services. Contracted hStream subscriptions rose to approximately 5.79 million from 5.54 million.
Cash and marketable securities totaled $71.1 million at year-end ($40.3 million cash and equivalents; $30.8 million marketable securities). Working capital was positive $11.8 million, versus negative $2.8 million a year earlier. The company had no debt outstanding and all $50 million of its revolving credit facility available, subject to covenants. Investing cash outflow was $56.6 million, including $25.8 million for capitalized software development, $2.2 million for property and equipment, and $6.6 million paid for eeds. Financing cash outflow was $13.0 million, including $8.9 million in share repurchases and $3.1 million in dividends.
Material changes and notable items
- Revenue growth reflected a $14.0 million increase in subscription revenue and $3.1 million contribution from recent acquisitions, partly offset by a $1.7 million decline in professional services.
- Operating income and net income increased, while depreciation and amortization rose to $41.1 million from $37.9 million. The effective tax rate fell to 18% from 22%.
- Operating cash flow improved with higher collections and operating efficiencies; days sales outstanding remained 46 days.
- The company incurred $1.1 million in severance charges associated with eliminating 33 roles during its enterprise consolidation.
- Other income included a $0.4 million gain on settlement of escrow proceeds tied to a prior investment sale. FY2022 included gains from an investment sale and remeasurement of the CloudCME interest.
- HealthStream initiated quarterly dividends in 2023, paying $0.10 per share for the year. In February 2024, the board approved a $0.028 quarterly dividend, a 12% increase from the prior quarter.
Outlook, risks, and contingencies
The filing provides no specific revenue, earnings, or margin guidance. Management says cash, securities, operating cash flow, and available credit should fund anticipated needs, product development, dividends, repurchases, and capital expenditures for at least the next 12 months and the foreseeable future. It reported approximately $541 million of remaining performance obligations at year-end, with approximately 42% expected to be recognized over the 12 months ending December 31, 2024.
Management cited inflation, elevated interest rates, labor-market pressures, uncertain customer spending, and geopolitical conditions as ongoing challenges. Key risks include customer renewals and concentration, healthcare-sector spending and reimbursement changes, competition, execution of the single-platform strategy and acquisitions, talent retention, cybersecurity and privacy obligations, service availability, and regulation of healthcare education and AI. No legal proceedings were reported in Item 3; the notes state that pending or threatened matters are not expected by management to have a material adverse effect. The company was in compliance with credit covenants, and management reported effective disclosure controls and internal control over financial reporting. The auditor issued unqualified opinions on the financial statements and internal controls; revenue recognition was identified as a critical audit matter.
Important facts for investors to verify
- Confirm the reported $541 million remaining-performance-obligation figure and its expected recognition schedule.
- Assess whether subscription growth and renewal rates can offset continued weakness in professional services and customer budget pressures.
- Review cash generation against elevated software-development investment, dividends, and share repurchases.
- Monitor the impact of the 33-role consolidation and whether expected efficiencies are sustained.
- Evaluate cybersecurity, privacy, and AI-related exposures, including risks involving third-party providers and acquired businesses.
- Consider the assumptions behind adjusted EBITDA and its reconciliation to GAAP net income.